Sarepta Therapeutics Inc.
Organization details
- Legal name
- Sarepta Therapeutics Inc.
- Former names
- AVI Biopharma Inc Antivirals Inc
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Cambridge
- Headquarters state / province
- Massachusetts
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- SRPT
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0000873303
- EIN
- 93-0797222
- Wikidata ID
- Q15109846
Board of directors
-
Claude Nicaise · DirectorSince 2023
-
Deirdre P. Connelly · DirectorSince 2024
-
Douglas S. Ingram · Director · Chief Executive OfficerSince 2023
-
Hans Lennart Rudolf Wigzell · DirectorSince 2023
-
Kathryn Jean Boor · DirectorSince 2023
-
M. Kathleen Behrens · DirectorSince 2023
-
Michael Andrew Chambers · DirectorSince 2023
-
Michael Severino · Director · Chief Executive OfficerSince 2026
-
Richard Barry · DirectorSince 2023
-
Stephen Mayo · DirectorSince 2023
Chief executives
Director election results
Annual meeting of June 4, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
79.0%
-
84.2%
-
94.5%
-
97.4%
-
98.8%
Board connections
8 of this board's directors also sit on 13 other boards. 9 are in the same sector.
-
Filana Therapeutics Inc. Same sectorvia Claude Nicaise and Richard Barry
-
Allogene Therapeutics Inc. Same sectorvia Stephen Mayo
-
Arrowhead Pharmaceuticals Inc. Same sectorvia Douglas S. Ingram
- via Michael Severino
- via Claude Nicaise
-
Gain Therapeutics Inc. Same sectorvia Claude Nicaise
- via Kathryn Jean Boor
- via Deirdre P. Connelly
- via Deirdre P. Connelly
-
Merck & Company Inc. Same sectorvia Stephen Mayo
-
MiMedx Group Inc Same sectorvia M. Kathleen Behrens
-
Relay Therapeutics Inc. Same sectorvia Douglas S. Ingram
-
Viatris Inc. Same sectorvia Michael Severino
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $417,410
- 2 sales by 2 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 4, 2026 | Estepan Ian Michael Officer (Chief Operating Officer) | Shares withheld for tax | −24,799 | $22.22 | $551,034 |
| Sep 4, 2026 | Rodino-Klapac Louise Officer (President, R&D and Tech Ops) | Shares withheld for tax | −21,423 | $22.22 | $476,019 |
| Sep 4, 2026 | Rothfuss Cristin Officer (EVP, General Counsel) | Shares withheld for tax | −22,025 | $22.22 | $489,396 |
| Sep 4, 2026 | Wong Ryan Ho-Yan Officer (Chief Financial Officer) | Shares withheld for tax | −13,272 | $22.22 | $294,904 |
| Jul 28, 2026 | Michael Severino Director, Officer (Chief Executive Officer) | Grant or award | +756,104 | — | — |
| Jun 4, 2026 | Kathryn Jean Boor Director | Grant or award | +16,875 | — | — |
| Jun 4, 2026 | Stephen Mayo Director | Grant or award | +16,875 | — | — |
| Jun 4, 2026 | Hans Lennart Rudolf Wigzell Director | Grant or award | +16,875 | — | — |
| Jun 4, 2026 | M. Kathleen Behrens Director | Grant or award | +16,875 | — | — |
| Jun 4, 2026 | Deirdre P. Connelly Director | Grant or award | +16,875 | — | — |
| Jun 4, 2026 | Claude Nicaise Director | Grant or award | +16,875 | — | — |
| Jun 4, 2026 | Michael Andrew Chambers Director | Grant or award | +16,875 | — | — |
| Jun 4, 2026 | Richard Barry Director | Grant or award | +16,875 | — | — |
| Mar 12, 2026 | Stephen Mayo Director | Open-market sale | −7,239 | $17.02 | $123,208 |
| Mar 11, 2026 | Estepan Ian Michael Officer (Chief Operating Officer) | Shares withheld for tax | −1,097 | $17.03 | $18,682 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Sarepta Therapeutics Inc.
Who is the CEO of Sarepta Therapeutics Inc.?
Michael Severino has been Sarepta Therapeutics Inc.'s Chief Executive Officer since July 2026.
How many directors are on Sarepta Therapeutics Inc.'s board?
Sarepta Therapeutics Inc.'s board has 10 directors: Claude Nicaise, Deirdre P. Connelly, Douglas S. Ingram, Hans Lennart Rudolf Wigzell, Kathryn Jean Boor, M. Kathleen Behrens, Michael Andrew Chambers, Michael Severino, Richard Barry and Stephen Mayo.
Are Sarepta Therapeutics Inc. insiders buying or selling shares?
Over the last 12 months, Sarepta Therapeutics Inc. insiders made no open-market purchases and sold $417,410 of shares in 2 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="sarepta-therapeutics-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.